In the last 12 months, insiders at Verona Pharma plc ($VRNA) filed 351 transactions with the SEC: 4 open-market purchases totaling $579,386 and 86 sales totaling $69,074,239. Net insider sentiment: net selling.
Verona Pharma plc operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Hahn Mark W (Chief Financial Officer) — 61 transactions totaling $34,829,890
- ZACCARDELLI DAVID (President and CEO) — 61 transactions totaling $34,829,271
- Rickard Kathleen A. (Chief Medical Officer) — 43 transactions totaling $6,308,856
- Sinha Vikas (Director) — 28 transactions totaling $3,498,854
- Fisher Andrew (General Counsel) — 30 transactions totaling $2,910,063
View all SEC Filings for Verona Pharma plc (VRNA).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 7, 2025 | Ullman Anders | Director | M | Ordinary Shares | 72000 | $0.00 | 72,000.0000 | 727,223,000 | 9999.99% | 0.01% |
| Oct. 7, 2025 | Austwick Michael | Director | D | Share Options (Right to Buy) | 144000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.02% |
| Oct. 7, 2025 | Austwick Michael | Director | M | Restricted Share Unit | 72000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Austwick Michael | Director | D | Ordinary Shares | 72000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Austwick Michael | Director | M | Ordinary Shares | 72000 | $0.00 | 72,000.0000 | 727,223,000 | 9999.99% | 0.01% |
| Oct. 7, 2025 | Austwick Michael | Director | D | Ordinary Shares | 12712 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.00% |
| Oct. 7, 2025 | Hahn Mark W | Chief Financial Officer | M | Restricted Share Unit | 1649952 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.23% |
| Oct. 7, 2025 | Hahn Mark W | Chief Financial Officer | A | Restricted Share Unit | 1649952 | $0.00 | 1,649,952.0000 | 727,223,000 | 9999.99% | 0.23% |
| Oct. 7, 2025 | Sinha Vikas | Director | D | Ordinary Shares | 72000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Hahn Mark W | Chief Financial Officer | M | Restricted Share Unit | 445536 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.06% |
| Oct. 7, 2025 | Hahn Mark W | Chief Financial Officer | M | Restricted Share Unit | 389792 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.05% |
| Oct. 7, 2025 | Hahn Mark W | Chief Financial Officer | M | Restricted Share Unit | 800000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.11% |
| Oct. 7, 2025 | Hahn Mark W | Chief Financial Officer | D | Ordinary Shares | 3285280 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.45% |
| Oct. 7, 2025 | Hahn Mark W | Chief Financial Officer | M | Ordinary Shares | 3285280 | $0.00 | 3,285,280.0000 | 727,223,000 | 9999.99% | 0.45% |
| Oct. 7, 2025 | Hahn Mark W | Chief Financial Officer | D | Ordinary Shares | 11264968 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 1.55% |
| Oct. 7, 2025 | Rickard Kathleen A. | Chief Medical Officer | D | Share Options (Right to Buy) | 100000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Rickard Kathleen A. | Chief Medical Officer | D | Share Options (Right to Buy) | 560000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.08% |
| Oct. 7, 2025 | Rickard Kathleen A. | Chief Medical Officer | M | Restricted Share Unit | 618760 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.09% |
| Oct. 7, 2025 | Rickard Kathleen A. | Chief Medical Officer | A | Restricted Share Unit | 618760 | $0.00 | 618,760.0000 | 727,223,000 | 9999.99% | 0.09% |
| Oct. 7, 2025 | Rickard Kathleen A. | Chief Medical Officer | M | Restricted Share Unit | 200000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.03% |
| Oct. 7, 2025 | Rickard Kathleen A. | Chief Medical Officer | M | Restricted Share Unit | 167056 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.02% |
| Oct. 7, 2025 | Rickard Kathleen A. | Chief Medical Officer | M | Restricted Share Unit | 146168 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.02% |
| Oct. 7, 2025 | Rickard Kathleen A. | Chief Medical Officer | D | Ordinary Shares | 1131984 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.16% |
| Oct. 7, 2025 | Rickard Kathleen A. | Chief Medical Officer | M | Ordinary Shares | 1131984 | $0.00 | 1,131,984.0000 | 727,223,000 | 9999.99% | 0.16% |
| Oct. 7, 2025 | Rickard Kathleen A. | Chief Medical Officer | D | Ordinary Shares | 2432868 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.33% |
| Oct. 7, 2025 | ZACCARDELLI DAVID | President and CEO | M | Restricted Share Unit | 1649952 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.23% |
| Oct. 7, 2025 | ZACCARDELLI DAVID | President and CEO | A | Restricted Share Unit | 1649952 | $0.00 | 1,649,952.0000 | 727,223,000 | 9999.99% | 0.23% |
| Oct. 7, 2025 | ZACCARDELLI DAVID | President and CEO | M | Restricted Share Unit | 445536 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.06% |
| Oct. 7, 2025 | ZACCARDELLI DAVID | President and CEO | M | Restricted Share Unit | 389792 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.05% |
| Oct. 7, 2025 | ZACCARDELLI DAVID | President and CEO | M | Restricted Share Unit | 800000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.11% |
| Oct. 7, 2025 | ZACCARDELLI DAVID | President and CEO | D | Ordinary Shares | 3285280 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.45% |
| Oct. 7, 2025 | ZACCARDELLI DAVID | President and CEO | M | Ordinary Shares | 3285280 | $0.00 | 3,285,280.0000 | 727,223,000 | 9999.99% | 0.45% |
| Oct. 7, 2025 | ZACCARDELLI DAVID | President and CEO | D | Ordinary Shares | 12176144 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 1.67% |
| Oct. 7, 2025 | Fisher Andrew | General Counsel | D | Share Options (Right to Buy) | 2240000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.31% |
| Oct. 7, 2025 | Fisher Andrew | General Counsel | M | Restricted Share Unit | 618760 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.09% |
| Oct. 7, 2025 | Fisher Andrew | General Counsel | A | Restricted Share Unit | 618760 | $0.00 | 618,760.0000 | 727,223,000 | 9999.99% | 0.09% |
| Oct. 7, 2025 | Fisher Andrew | General Counsel | M | Restricted Share Unit | 167056 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.02% |
| Oct. 7, 2025 | Fisher Andrew | General Counsel | M | Restricted Share Unit | 146168 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.02% |
| Oct. 7, 2025 | Fisher Andrew | General Counsel | D | Ordinary Shares | 931984 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.13% |
| Oct. 7, 2025 | Fisher Andrew | General Counsel | M | Ordinary Shares | 931984 | $0.00 | 931,984.0000 | 727,223,000 | 9999.99% | 0.13% |
| Oct. 7, 2025 | Fisher Andrew | General Counsel | D | Ordinary Shares | 417903 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.06% |
| Oct. 7, 2025 | Ullman Anders | Director | M | Restricted Share Unit | 72000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Ullman Anders | Director | D | Ordinary Shares | 72000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Ullman Anders | Director | D | Ordinary Shares | 358856 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.05% |
| Oct. 7, 2025 | ACKERMANN CHRISTINA | Director | D | Share Options (Right to Buy) | 144000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.02% |
| Oct. 7, 2025 | ACKERMANN CHRISTINA | Director | D | Share Options (Right to Buy) | 200000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.03% |
| Oct. 7, 2025 | ACKERMANN CHRISTINA | Director | M | Restricted Share Unit | 72000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | ACKERMANN CHRISTINA | Director | D | Ordinary Shares | 72000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | ACKERMANN CHRISTINA | Director | M | Ordinary Shares | 72000 | $0.00 | 72,000.0000 | 727,223,000 | 9999.99% | 0.01% |
| Oct. 7, 2025 | ACKERMANN CHRISTINA | Director | D | Ordinary Shares | 64072 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Cunningham Kenneth | Director | D | Share Options (Right to Buy) | 64000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Cunningham Kenneth | Director | D | Share Options (Right to Buy) | 240000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.03% |
| Oct. 7, 2025 | Cunningham Kenneth | Director | D | Share Options (Right to Buy) | 96000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Cunningham Kenneth | Director | D | Share Options (Right to Buy) | 200000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.03% |
| Oct. 7, 2025 | Cunningham Kenneth | Director | M | Restricted Share Unit | 72000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Cunningham Kenneth | Director | D | Ordinary Shares | 72000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Cunningham Kenneth | Director | M | Ordinary Shares | 72000 | $0.00 | 72,000.0000 | 727,223,000 | 9999.99% | 0.01% |
| Oct. 7, 2025 | Cunningham Kenneth | Director | D | Ordinary Shares | 79776 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Brady James Aloysius | Director | D | Share Options (Right to Buy) | 240000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.03% |
| Oct. 7, 2025 | Brady James Aloysius | Director | D | Share Options (Right to Buy) | 96000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Brady James Aloysius | Director | D | Share Options (Right to Buy) | 288000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.04% |
| Oct. 7, 2025 | Brady James Aloysius | Director | M | Restricted Share Unit | 72000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Brady James Aloysius | Director | D | Ordinary Shares | 72000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Brady James Aloysius | Director | M | Ordinary Shares | 72000 | $0.00 | 72,000.0000 | 727,223,000 | 9999.99% | 0.01% |
| Oct. 7, 2025 | Brady James Aloysius | Director | D | Ordinary Shares | 23176 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.00% |
| Oct. 7, 2025 | Edwards Martin | Director | D | Share Options (Right to Buy) | 64000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Edwards Martin | Director | D | Share Options (Right to Buy) | 240000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.03% |
| Oct. 7, 2025 | Edwards Martin | Director | D | Share Options (Right to Buy) | 96000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Edwards Martin | Director | D | Share Options (Right to Buy) | 200000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.03% |
| Oct. 7, 2025 | Edwards Martin | Director | M | Restricted Share Unit | 72000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Edwards Martin | Director | D | Ordinary Shares | 72000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Edwards Martin | Director | M | Ordinary Shares | 72000 | $0.00 | 72,000.0000 | 727,223,000 | 9999.99% | 0.01% |
| Oct. 7, 2025 | Edwards Martin | Director | D | Ordinary Shares | 157992 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.02% |
| Oct. 7, 2025 | EBSWORTH DAVID R | Director | M | Restricted Share Unit | 72000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | EBSWORTH DAVID R | Director | D | Ordinary Shares | 617600 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.08% |
| Oct. 7, 2025 | EBSWORTH DAVID R | Director | D | Ordinary Shares | 72000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | EBSWORTH DAVID R | Director | M | Ordinary Shares | 72000 | $0.00 | 72,000.0000 | 727,223,000 | 9999.99% | 0.01% |
| Oct. 7, 2025 | EBSWORTH DAVID R | Director | D | Ordinary Shares | 880499 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.12% |
| Oct. 7, 2025 | Deschamps Lisa | Director | D | Share Options (Right to Buy) | 64000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Deschamps Lisa | Director | D | Share Options (Right to Buy) | 240000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.03% |
| Oct. 7, 2025 | Deschamps Lisa | Director | D | Share Options (Right to Buy) | 96000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Deschamps Lisa | Director | D | Share Options (Right to Buy) | 200000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.03% |
| Oct. 7, 2025 | Deschamps Lisa | Director | M | Restricted Share Unit | 72000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Deschamps Lisa | Director | D | Ordinary Shares | 72000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Deschamps Lisa | Director | M | Ordinary Shares | 72000 | $0.00 | 72,000.0000 | 727,223,000 | 9999.99% | 0.01% |
| Oct. 7, 2025 | Deschamps Lisa | Director | D | Ordinary Shares | 84856 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Sinha Vikas | Director | D | Share Options (Right to Buy) | 64000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Sinha Vikas | Director | D | Share Options (Right to Buy) | 240000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.03% |
| Oct. 7, 2025 | Sinha Vikas | Director | D | Share Options (Right to Buy) | 96000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Sinha Vikas | Director | D | Share Options (Right to Buy) | 384 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.00% |
| Oct. 7, 2025 | Sinha Vikas | Director | M | Restricted Share Unit | 72000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Sinha Vikas | Director | M | Ordinary Shares | 72000 | $0.00 | 72,000.0000 | 727,223,000 | 9999.99% | 0.01% |
| Oct. 7, 2025 | Sinha Vikas | Director | D | Ordinary Shares | 94112 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | SHAH MAHENDRA | Director | D | Share Options (Right to Buy) | 64000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | SHAH MAHENDRA | Director | D | Share Options (Right to Buy) | 240000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.03% |
| Oct. 7, 2025 | SHAH MAHENDRA | Director | D | Share Options (Right to Buy) | 96000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | SHAH MAHENDRA | Director | D | Share Options (Right to Buy) | 200000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.03% |
| Oct. 7, 2025 | SHAH MAHENDRA | Director | M | Restricted Share Unit | 72000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | SHAH MAHENDRA | Director | D | Ordinary Shares | 72000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | SHAH MAHENDRA | Director | M | Ordinary Shares | 72000 | $0.00 | 72,000.0000 | 727,223,000 | 9999.99% | 0.01% |
| Oct. 7, 2025 | SHAH MAHENDRA | Director | D | Ordinary Shares | 93472 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Ullman Anders | Director | D | Share Options (Right to Buy) | 64000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Ullman Anders | Director | D | Share Options (Right to Buy) | 240000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.03% |
| Oct. 7, 2025 | Ullman Anders | Director | D | Share Options (Right to Buy) | 96000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Ullman Anders | Director | D | Share Options (Right to Buy) | 200000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.03% |
| Aug. 29, 2025 | Hahn Mark W | Chief Financial Officer | G | Ordinary Shares | 1200000 | $0.00 | 11,264,968.0000 | 727,223,000 | 9.63% | 0.17% |
| Aug. 29, 2025 | Rickard Kathleen A. | Chief Medical Officer | G | Ordinary Shares | 189600 | $0.00 | 2,417,872.0000 | 727,223,000 | 7.27% | 0.03% |
| Aug. 29, 2025 | ZACCARDELLI DAVID | President and CEO | G | Ordinary Shares | 1200000 | $0.00 | 12,176,144.0000 | 727,223,000 | 8.97% | 0.17% |
| Aug. 1, 2025 | Cunningham Kenneth | Director | M | Ordinary Shares | 24000 | $0.00 | 90,584.0000 | 727,223,000 | 36.04% | 0.00% |
| Aug. 1, 2025 | Cunningham Kenneth | Director | S | Ordinary Shares | 10808 | $13.14 | 79,776.0000 | 727,223,000 | 11.93% | 0.00% |
| Aug. 1, 2025 | Cunningham Kenneth | Director | M | Restricted Stock Units | 24000 | $0.00 | 72,000.0000 | 727,223,000 | 25.00% | 0.00% |
| Aug. 1, 2025 | Deschamps Lisa | Director | M | Ordinary Shares | 24000 | $0.00 | 94,320.0000 | 727,223,000 | 34.13% | 0.00% |
| Aug. 1, 2025 | Deschamps Lisa | Director | S | Ordinary Shares | 9464 | $13.14 | 84,856.0000 | 727,223,000 | 10.03% | 0.00% |
| Aug. 1, 2025 | Deschamps Lisa | Director | M | Restricted Stock Units | 24000 | $0.00 | 72,000.0000 | 727,223,000 | 25.00% | 0.00% |
| Aug. 1, 2025 | Fisher Andrew | General Counsel | M | Ordinary Shares | 20888 | $0.00 | 427,487.0000 | 727,223,000 | 5.14% | 0.00% |
| Aug. 1, 2025 | Fisher Andrew | General Counsel | S | Ordinary Shares | 9584 | $13.14 | 417,903.0000 | 727,223,000 | 2.24% | 0.00% |
| Aug. 1, 2025 | Fisher Andrew | General Counsel | M | Restricted Stock Units | 20888 | $0.00 | 146,168.0000 | 727,223,000 | 12.50% | 0.00% |
| Aug. 1, 2025 | Hahn Mark W | Chief Financial Officer | M | Ordinary Shares | 255696 | $0.00 | 12,673,880.0000 | 727,223,000 | 2.06% | 0.04% |
| Aug. 1, 2025 | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 208912 | $13.14 | 12,464,968.0000 | 727,223,000 | 1.65% | 0.03% |
| Aug. 1, 2025 | Hahn Mark W | Chief Financial Officer | M | Restricted Stock Units | 200000 | $0.00 | 800,000.0000 | 727,223,000 | 20.00% | 0.03% |
| Aug. 1, 2025 | Hahn Mark W | Chief Financial Officer | M | Restricted Stock Units | 55696 | $0.00 | 389,792.0000 | 727,223,000 | 12.50% | 0.01% |
| Aug. 1, 2025 | Rickard Kathleen A. | Chief Medical Officer | M | Ordinary Shares | 70888 | $0.00 | 2,665,808.0000 | 727,223,000 | 2.73% | 0.01% |
| Aug. 1, 2025 | Rickard Kathleen A. | Chief Medical Officer | S | Ordinary Shares | 58336 | $13.14 | 2,607,472.0000 | 727,223,000 | 2.19% | 0.01% |
| Aug. 1, 2025 | Rickard Kathleen A. | Chief Medical Officer | M | Restricted Stock Units | 50000 | $0.00 | 200,000.0000 | 727,223,000 | 20.00% | 0.01% |
| Aug. 1, 2025 | Rickard Kathleen A. | Chief Medical Officer | M | Restricted Stock Units | 20888 | $0.00 | 146,168.0000 | 727,223,000 | 12.50% | 0.00% |
| Aug. 1, 2025 | ACKERMANN CHRISTINA | Director | M | Ordinary Shares | 24000 | $0.00 | 65,880.0000 | 727,223,000 | 57.31% | 0.00% |
| Aug. 1, 2025 | ACKERMANN CHRISTINA | Director | S | Ordinary Shares | 1808 | $13.14 | 64,072.0000 | 727,223,000 | 2.74% | 0.00% |
| Aug. 1, 2025 | ACKERMANN CHRISTINA | Director | M | Restricted Stock Units | 24000 | $0.00 | 72,000.0000 | 727,223,000 | 25.00% | 0.00% |
| Aug. 1, 2025 | Austwick Michael | Director | M | Ordinary Shares | 24000 | $0.00 | 24,000.0000 | 727,223,000 | 9999.99% | 0.00% |
| Aug. 1, 2025 | Austwick Michael | Director | S | Ordinary Shares | 11288 | $13.14 | 12,712.0000 | 727,223,000 | 47.03% | 0.00% |
| Aug. 1, 2025 | Austwick Michael | Director | M | Restricted Stock Units | 24000 | $0.00 | 72,000.0000 | 727,223,000 | 25.00% | 0.00% |
| Aug. 1, 2025 | Brady James Aloysius | Director | M | Ordinary Shares | 24000 | $0.00 | 24,000.0000 | 727,223,000 | 9999.99% | 0.00% |
| Aug. 1, 2025 | Brady James Aloysius | Director | S | Ordinary Shares | 824 | $13.14 | 23,176.0000 | 727,223,000 | 3.43% | 0.00% |
| Aug. 1, 2025 | Brady James Aloysius | Director | M | Restricted Stock Units | 24000 | $0.00 | 72,000.0000 | 727,223,000 | 25.00% | 0.00% |
| Aug. 1, 2025 | ZACCARDELLI DAVID | President and CEO | M | Ordinary Shares | 255696 | $0.00 | 13,585,056.0000 | 727,223,000 | 1.92% | 0.04% |
| Aug. 1, 2025 | ZACCARDELLI DAVID | President and CEO | S | Ordinary Shares | 208912 | $13.14 | 13,376,144.0000 | 727,223,000 | 1.54% | 0.03% |
| Aug. 1, 2025 | ZACCARDELLI DAVID | President and CEO | M | Restricted Stock Units | 200000 | $0.00 | 800,000.0000 | 727,223,000 | 20.00% | 0.03% |
| Aug. 1, 2025 | ZACCARDELLI DAVID | President and CEO | M | Restricted Stock Units | 55696 | $0.00 | 389,792.0000 | 727,223,000 | 12.50% | 0.01% |
| Aug. 1, 2025 | EBSWORTH DAVID R | Director | M | Ordinary Shares | 24000 | $0.00 | 1,500,003.0000 | 727,223,000 | 1.63% | 0.00% |
| Aug. 1, 2025 | EBSWORTH DAVID R | Director | S | Ordinary Shares | 1904 | $13.14 | 1,498,099.0000 | 727,223,000 | 0.13% | 0.00% |
| Aug. 1, 2025 | EBSWORTH DAVID R | Director | M | Restricted Stock Units | 24000 | $0.00 | 72,000.0000 | 727,223,000 | 25.00% | 0.00% |
| Aug. 1, 2025 | Edwards Martin | Director | M | Ordinary Shares | 24000 | $0.00 | 168,800.0000 | 727,223,000 | 16.57% | 0.00% |
| Aug. 1, 2025 | Edwards Martin | Director | S | Ordinary Shares | 10808 | $13.14 | 157,992.0000 | 727,223,000 | 6.40% | 0.00% |
| Aug. 1, 2025 | Edwards Martin | Director | M | Restricted Stock Units | 24000 | $0.00 | 72,000.0000 | 727,223,000 | 25.00% | 0.00% |
| Aug. 1, 2025 | SHAH MAHENDRA | Director | M | Ordinary Shares | 24000 | $0.00 | 97,080.0000 | 727,223,000 | 32.84% | 0.00% |
| Aug. 1, 2025 | SHAH MAHENDRA | Director | S | Ordinary Shares | 3608 | $13.14 | 93,472.0000 | 727,223,000 | 3.72% | 0.00% |
| Aug. 1, 2025 | SHAH MAHENDRA | Director | M | Restricted Stock Units | 24000 | $0.00 | 72,000.0000 | 727,223,000 | 25.00% | 0.00% |
| Aug. 1, 2025 | Sinha Vikas | Director | M | Ordinary Shares | 24000 | $0.00 | 98,440.0000 | 727,223,000 | 32.24% | 0.00% |
| Aug. 1, 2025 | Sinha Vikas | Director | S | Ordinary Shares | 4328 | $13.14 | 94,112.0000 | 727,223,000 | 4.40% | 0.00% |
| Aug. 1, 2025 | Sinha Vikas | Director | M | Restricted Stock Units | 24000 | $0.00 | 72,000.0000 | 727,223,000 | 25.00% | 0.00% |
| Aug. 1, 2025 | Ullman Anders | Director | M | Ordinary Shares | 24000 | $0.00 | 358,856.0000 | 727,223,000 | 7.17% | 0.00% |
| Aug. 1, 2025 | Ullman Anders | Director | M | Restricted Stock Units | 24000 | $0.00 | 72,000.0000 | 727,223,000 | 25.00% | 0.00% |
| July 7, 2025 | Rickard Kathleen A. | Chief Medical Officer | M | Restricted Share Units | 86064 | $0.00 | 167,056.0000 | 727,223,000 | 34.00% | 0.01% |
| July 8, 2025 | Fisher Andrew | General Counsel | F | Ordinary Shares | 39464 | $11.44 | 406,599.0000 | 727,223,000 | 8.85% | 0.01% |
| July 7, 2025 | Fisher Andrew | General Counsel | A | Restricted Share Units | 253120 | $0.00 | 253,120.0000 | 727,223,000 | 9999.99% | 0.03% |
| July 7, 2025 | Fisher Andrew | General Counsel | M | Restricted Share Units | 86064 | $0.00 | 167,056.0000 | 727,223,000 | 34.00% | 0.01% |
| July 8, 2025 | Hahn Mark W | Chief Financial Officer | F | Ordinary Shares | 90320 | $11.44 | 12,418,184.0000 | 727,223,000 | 0.72% | 0.01% |
| July 7, 2025 | Hahn Mark W | Chief Financial Officer | A | Restricted Share Units | 675048 | $0.00 | 675,048.0000 | 727,223,000 | 9999.99% | 0.09% |
| July 7, 2025 | Hahn Mark W | Chief Financial Officer | M | Restricted Share Units | 229512 | $0.00 | 445,536.0000 | 727,223,000 | 34.00% | 0.03% |
| July 7, 2025 | Rickard Kathleen A. | Chief Medical Officer | M | Ordinary Shares | 86064 | $0.00 | 2,632,536.0000 | 727,223,000 | 3.38% | 0.01% |
| July 8, 2025 | Rickard Kathleen A. | Chief Medical Officer | F | Ordinary Shares | 37616 | $11.44 | 2,594,920.0000 | 727,223,000 | 1.43% | 0.01% |
| July 7, 2025 | Rickard Kathleen A. | Chief Medical Officer | A | Restricted Share Units | 253120 | $0.00 | 253,120.0000 | 727,223,000 | 9999.99% | 0.03% |
| July 7, 2025 | Fisher Andrew | General Counsel | M | Ordinary Shares | 86064 | $0.00 | 446,063.0000 | 727,223,000 | 23.91% | 0.01% |
| July 7, 2025 | ZACCARDELLI DAVID | President and CEO | M | Restricted Share Units | 229512 | $0.00 | 445,536.0000 | 727,223,000 | 34.00% | 0.03% |
| July 7, 2025 | ZACCARDELLI DAVID | President and CEO | A | Restricted Share Units | 675048 | $0.00 | 675,048.0000 | 727,223,000 | 9999.99% | 0.09% |
| July 8, 2025 | ZACCARDELLI DAVID | President and CEO | F | Ordinary Shares | 90320 | $11.44 | 13,329,360.0000 | 727,223,000 | 0.67% | 0.01% |
| July 7, 2025 | ZACCARDELLI DAVID | President and CEO | M | Ordinary Shares | 229512 | $0.00 | 13,419,680.0000 | 727,223,000 | 1.74% | 0.03% |
| July 7, 2025 | Hahn Mark W | Chief Financial Officer | M | Ordinary Shares | 229512 | $0.00 | 12,508,504.0000 | 727,223,000 | 1.87% | 0.03% |
| June 16, 2025 | Fisher Andrew | General Counsel | M | Share Options (Right to Buy) | 80000 | $0.00 | 2,240,000.0000 | 652,311,000 | 3.45% | 0.01% |
| June 16, 2025 | Fisher Andrew | General Counsel | S | Ordinary Shares | 80000 | $11.53 | 359,999.0000 | 652,311,000 | 18.18% | 0.01% |
| June 16, 2025 | Fisher Andrew | General Counsel | M | Ordinary Shares | 80000 | $2.01 | 439,999.0000 | 652,311,000 | 22.22% | 0.01% |
| May 15, 2025 | Fisher Andrew | General Counsel | M | Ordinary Shares | 80000 | $2.01 | 439,999.0000 | 652,311,000 | 22.22% | 0.01% |
| May 15, 2025 | Fisher Andrew | General Counsel | M | Share Options (Right to Buy) | 80000 | $0.00 | 2,320,000.0000 | 652,311,000 | 3.33% | 0.01% |
| June 11, 2025 | ZACCARDELLI DAVID | President and CEO | S | Ordinary Shares | 400000 | $11.40 | 13,190,168.0000 | 652,311,000 | 2.94% | 0.06% |
| June 11, 2025 | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 400000 | $11.40 | 12,278,992.0000 | 652,311,000 | 3.15% | 0.06% |
| May 28, 2025 | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 162704 | $9.30 | 12,883,856.0000 | 652,311,000 | 1.25% | 0.02% |
| May 27, 2025 | ZACCARDELLI DAVID | President and CEO | S | Ordinary Shares | 33600 | $9.53 | 13,956,568.0000 | 652,311,000 | 0.24% | 0.01% |
| May 28, 2025 | ZACCARDELLI DAVID | President and CEO | S | Ordinary Shares | 157704 | $9.30 | 13,798,864.0000 | 652,311,000 | 1.13% | 0.02% |
| May 29, 2025 | ZACCARDELLI DAVID | President and CEO | S | Ordinary Shares | 208696 | $9.33 | 13,590,168.0000 | 652,311,000 | 1.51% | 0.03% |
| May 27, 2025 | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 32432 | $9.53 | 13,046,560.0000 | 652,311,000 | 0.25% | 0.00% |
| May 29, 2025 | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 204864 | $9.33 | 12,678,992.0000 | 652,311,000 | 1.59% | 0.03% |
| April 29, 2025 | Sinha Vikas | Director | S | Ordinary Shares | 39616 | $8.92 | 74,440.0000 | 652,311,000 | 34.73% | 0.01% |
| April 29, 2025 | Sinha Vikas | Director | M | Share Options (Right to Buy) | 120384 | $0.00 | 0.0000 | 652,311,000 | 100.00% | 0.02% |
| April 29, 2025 | Sinha Vikas | Director | M | Share Options (Right to Buy) | 39616 | $0.00 | 160,384.0000 | 652,311,000 | 19.81% | 0.01% |
| April 29, 2025 | Sinha Vikas | Director | M | Ordinary Shares | 120384 | $1.70 | 194,824.0000 | 652,311,000 | 161.72% | 0.02% |
| May 20, 2025 | Sinha Vikas | Director | M | Ordinary Shares | 160000 | $0.50 | 234,440.0000 | 652,311,000 | 214.94% | 0.02% |
| May 20, 2025 | Sinha Vikas | Director | S | Ordinary Shares | 160000 | $9.39 | 74,440.0000 | 652,311,000 | 68.25% | 0.02% |
| May 20, 2025 | Sinha Vikas | Director | M | Share Options (Right to Buy) | 160000 | $0.00 | 384.0000 | 652,311,000 | 99.76% | 0.02% |
| April 29, 2025 | Sinha Vikas | Director | S | Ordinary Shares | 120384 | $8.92 | 74,440.0000 | 652,311,000 | 61.79% | 0.02% |
| April 29, 2025 | Sinha Vikas | Director | M | Ordinary Shares | 39616 | $0.50 | 114,056.0000 | 652,311,000 | 53.22% | 0.01% |
| May 14, 2025 | ACKERMANN CHRISTINA | Director | S | Ordinary Shares | 40000 | $8.44 | 41,880.0000 | 652,311,000 | 48.85% | 0.01% |
| May 15, 2025 | Fisher Andrew | General Counsel | S | Ordinary Shares | 80000 | $8.57 | 359,999.0000 | 652,311,000 | 18.18% | 0.01% |
| May 15, 2025 | Fisher Andrew | General Counsel | M | Ordinary Shares | 80000 | $2.11 | 439,999.0000 | 652,311,000 | 22.22% | 0.01% |
| May 14, 2025 | ACKERMANN CHRISTINA | Director | M | Ordinary Shares | 40000 | $1.93 | 81,880.0000 | 652,311,000 | 95.51% | 0.01% |
| May 15, 2025 | Fisher Andrew | General Counsel | M | Share Options (Right to Buy) | 80000 | $0.00 | 2,320,000.0000 | 652,311,000 | 3.33% | 0.01% |
| May 14, 2025 | ACKERMANN CHRISTINA | Director | M | Share Options (Right to Buy) | 40000 | $0.00 | 200,000.0000 | 652,311,000 | 16.67% | 0.01% |
| May 6, 2025 | Rickard Kathleen A. | Chief Medical Officer | S | Ordinary Shares | 114984 | $8.82 | 2,546,472.0000 | 652,311,000 | 4.32% | 0.02% |
| May 1, 2025 | EBSWORTH DAVID R | Director | M | Stock Option (Right to Exercise) | 140000 | $0.00 | 0.0000 | 652,311,000 | 0.00% | 0.02% |
| May 1, 2025 | ZACCARDELLI DAVID | President and CEO | S | Ordinary Shares | 108272 | $8.95 | 14,268,904.0000 | 652,311,000 | 0.75% | 0.02% |
| May 1, 2025 | ZACCARDELLI DAVID | President and CEO | S | Ordinary Shares | 78736 | $8.95 | 14,390,168.0000 | 652,311,000 | 0.54% | 0.01% |
| May 1, 2025 | ZACCARDELLI DAVID | President and CEO | M | Restricted Share Units | 200000 | $0.00 | 1,000,000.0000 | 652,311,000 | 16.67% | 0.03% |
| May 2, 2025 | ZACCARDELLI DAVID | President and CEO | S | Ordinary Shares | 400000 | $9.09 | 13,990,168.0000 | 652,311,000 | 2.78% | 0.06% |
| May 1, 2025 | ZACCARDELLI DAVID | President and CEO | M | Ordinary Shares | 200000 | $0.00 | 14,468,904.0000 | 652,311,000 | 1.40% | 0.03% |
| May 1, 2025 | Rickard Kathleen A. | Chief Medical Officer | S | Ordinary Shares | 27336 | $8.95 | 2,633,320.0000 | 652,311,000 | 1.03% | 0.00% |
| May 1, 2025 | Rickard Kathleen A. | Chief Medical Officer | M | Ordinary Shares | 50000 | $0.00 | 2,683,320.0000 | 652,311,000 | 1.90% | 0.01% |
| May 1, 2025 | Rickard Kathleen A. | Chief Medical Officer | S | Ordinary Shares | 21864 | $8.95 | 2,661,456.0000 | 652,311,000 | 0.81% | 0.00% |
| May 1, 2025 | Rickard Kathleen A. | Chief Medical Officer | M | Restricted Share Units | 50000 | $0.00 | 250,000.0000 | 652,311,000 | 16.67% | 0.01% |
| May 1, 2025 | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 108272 | $8.95 | 13,357,728.0000 | 652,311,000 | 0.80% | 0.02% |
| May 1, 2025 | Hahn Mark W | Chief Financial Officer | M | Ordinary Shares | 200000 | $0.00 | 13,557,728.0000 | 652,311,000 | 1.50% | 0.03% |
| May 1, 2025 | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 78736 | $8.95 | 13,478,992.0000 | 652,311,000 | 0.58% | 0.01% |
| May 2, 2025 | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 400000 | $9.09 | 13,078,992.0000 | 652,311,000 | 2.97% | 0.06% |
| May 1, 2025 | EBSWORTH DAVID R | Director | M | Ordinary Shares | 140000 | $1.93 | 1,476,003.0000 | 652,311,000 | 10.48% | 0.02% |
| May 1, 2025 | Hahn Mark W | Chief Financial Officer | M | Restricted Share Units | 200000 | $0.00 | 1,000,000.0000 | 652,311,000 | 16.67% | 0.03% |
| April 29, 2025 | Sinha Vikas | Director | M | Ordinary Shares | 15048 | $1.70 | 89,488.0000 | 652,311,000 | 20.21% | 0.00% |
| April 29, 2025 | Sinha Vikas | Director | M | Ordinary Shares | 4952 | $0.50 | 79,392.0000 | 652,311,000 | 6.65% | 0.00% |
| April 29, 2025 | Sinha Vikas | Director | S | Ordinary Shares | 15048 | $8.92 | 74,440.0000 | 652,311,000 | 16.82% | 0.00% |
| Aug. 7, 2024 | Rickard Kathleen A. | Chief Medical Officer | A | Restricted Share Units | 300000 | $0.00 | 300,000.0000 | 648,217,000 | 9999.99% | 0.05% |
| April 29, 2025 | Rickard Kathleen A. | Chief Medical Officer | A | Restricted Share Units | 253120 | $0.00 | 253,120.0000 | 652,311,000 | 9999.99% | 0.04% |
| April 29, 2025 | Rickard Kathleen A. | Chief Medical Officer | M | Restricted Share Units | 86064 | $0.00 | 167,056.0000 | 652,311,000 | 34.00% | 0.01% |
| April 29, 2025 | Hahn Mark W | Chief Financial Officer | M | Ordinary Shares | 229512 | $0.00 | 13,556,360.0000 | 652,311,000 | 1.72% | 0.04% |
| April 29, 2025 | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 90360 | $8.98 | 13,466,000.0000 | 652,311,000 | 0.67% | 0.01% |
| Aug. 7, 2024 | Hahn Mark W | Chief Financial Officer | A | Restricted Share Units | 1200000 | $0.00 | 1,200,000.0000 | 648,217,000 | 9999.99% | 0.19% |
| April 29, 2025 | Hahn Mark W | Chief Financial Officer | A | Restricted Share Units | 675000 | $0.00 | 675,000.0000 | 652,311,000 | 9999.99% | 0.10% |
| April 29, 2025 | Hahn Mark W | Chief Financial Officer | M | Restricted Share Units | 229512 | $0.00 | 445,488.0000 | 652,311,000 | 34.00% | 0.04% |
| April 29, 2025 | Sinha Vikas | Director | M | Share Options (Right to Buy) | 4952 | $0.00 | 195,048.0000 | 652,311,000 | 2.48% | 0.00% |
| April 29, 2025 | Sinha Vikas | Director | M | Share Options (Right to Buy) | 15048 | $0.00 | 80,952.0000 | 652,311,000 | 15.68% | 0.00% |
| April 29, 2025 | Sinha Vikas | Director | S | Ordinary Shares | 4952 | $8.92 | 74,440.0000 | 652,311,000 | 6.24% | 0.00% |
| March 19, 2025 | Fisher Andrew | General Counsel | G | Ordinary Shares | 1 | $0.00 | 300,001.0000 | 652,311,000 | 0.00% | 0.00% |
| April 29, 2025 | Fisher Andrew | General Counsel | M | Ordinary Shares | 86064 | $0.00 | 386,065.0000 | 652,311,000 | 28.69% | 0.01% |
| April 29, 2025 | Fisher Andrew | General Counsel | S | Ordinary Shares | 26072 | $8.98 | 359,993.0000 | 652,311,000 | 6.75% | 0.00% |
| April 29, 2025 | Fisher Andrew | General Counsel | A | Restricted Share Units | 253120 | $0.00 | 253,120.0000 | 652,311,000 | 9999.99% | 0.04% |
| April 29, 2025 | Fisher Andrew | General Counsel | M | Restricted Share Units | 86064 | $0.00 | 167,056.0000 | 652,311,000 | 34.00% | 0.01% |
| April 29, 2025 | ZACCARDELLI DAVID | President and CEO | M | Ordinary Shares | 229512 | $0.00 | 14,467,536.0000 | 652,311,000 | 1.61% | 0.04% |
| April 29, 2025 | ZACCARDELLI DAVID | President and CEO | S | Ordinary Shares | 90360 | $8.98 | 14,377,176.0000 | 652,311,000 | 0.62% | 0.01% |
| Aug. 7, 2024 | ZACCARDELLI DAVID | President and CEO | A | Restricted Share Units | 1200000 | $0.00 | 1,200,000.0000 | 648,217,000 | 9999.99% | 0.19% |
| April 29, 2025 | ZACCARDELLI DAVID | President and CEO | A | Restricted Share Units | 675000 | $0.00 | 675,000.0000 | 652,311,000 | 9999.99% | 0.10% |
| April 29, 2025 | ZACCARDELLI DAVID | President and CEO | M | Restricted Share Units | 229512 | $0.00 | 445,488.0000 | 652,311,000 | 34.00% | 0.04% |
| April 29, 2025 | Rickard Kathleen A. | Chief Medical Officer | M | Ordinary Shares | 86064 | $0.00 | 2,695,040.0000 | 652,311,000 | 3.30% | 0.01% |
| April 29, 2025 | Rickard Kathleen A. | Chief Medical Officer | S | Ordinary Shares | 34384 | $8.98 | 2,660,656.0000 | 652,311,000 | 1.28% | 0.01% |
| April 25, 2025 | EBSWORTH DAVID R | Director | A | Restricted Share Units | 96000 | $0.00 | 96,000.0000 | 652,311,000 | 9999.99% | 0.01% |
| April 25, 2025 | Edwards Martin | Director | A | Restricted Share Units | 96000 | $0.00 | 96,000.0000 | 652,311,000 | 9999.99% | 0.01% |
| April 25, 2025 | Brady James Aloysius | Director | A | Restricted Share Units | 96000 | $0.00 | 96,000.0000 | 652,311,000 | 9999.99% | 0.01% |
| April 25, 2025 | ACKERMANN CHRISTINA | Director | A | Restricted Share Units | 96000 | $0.00 | 96,000.0000 | 652,311,000 | 9999.99% | 0.01% |
| April 25, 2025 | Ullman Anders | Director | A | Restricted Share Units | 96000 | $0.00 | 96,000.0000 | 652,311,000 | 9999.99% | 0.01% |
| April 25, 2025 | Sinha Vikas | Director | A | Restricted Share Units | 96000 | $0.00 | 96,000.0000 | 652,311,000 | 9999.99% | 0.01% |
| April 25, 2025 | SHAH MAHENDRA | Director | A | Restricted Share Units | 96000 | $0.00 | 96,000.0000 | 652,311,000 | 9999.99% | 0.01% |
| April 25, 2025 | Deschamps Lisa | Director | A | Restricted Share Units | 96000 | $0.00 | 96,000.0000 | 652,311,000 | 9999.99% | 0.01% |
| April 25, 2025 | Cunningham Kenneth | Director | A | Restricted Share Units | 96000 | $0.00 | 96,000.0000 | 652,311,000 | 9999.99% | 0.01% |
| April 25, 2025 | Austwick Michael | Director | A | Restricted Share Units | 96000 | $0.00 | 96,000.0000 | 652,311,000 | 9999.99% | 0.01% |
| March 12, 2025 | Rickard Kathleen A. | Chief Medical Officer | S | Ordinary Shares | 79264 | $8.35 | 2,608,976.0000 | 652,311,000 | 2.95% | 0.01% |
| Feb. 26, 2025 | EBSWORTH DAVID R | Director | M | Ordinary Shares | 200000 | $0.50 | 1,204,003.0000 | 652,311,000 | 19.92% | 0.03% |
| Feb. 26, 2025 | EBSWORTH DAVID R | Director | M | Share Option (Right to Exercise) | 100000 | $0.00 | 140,000.0000 | 652,311,000 | 41.67% | 0.02% |
| Feb. 26, 2025 | EBSWORTH DAVID R | Director | M | Share Option (Right to Exercise) | 96000 | $0.00 | 0.0000 | 652,311,000 | 100.00% | 0.01% |
| Feb. 26, 2025 | EBSWORTH DAVID R | Director | M | Share Option (Right to Exercise) | 200000 | $0.00 | 0.0000 | 652,311,000 | 100.00% | 0.03% |
| Feb. 26, 2025 | EBSWORTH DAVID R | Director | M | Share Option (Right to Exercise) | 64000 | $0.00 | 0.0000 | 652,311,000 | 100.00% | 0.01% |
| Feb. 26, 2025 | EBSWORTH DAVID R | Director | G | Ordinary Shares | 64000 | $0.00 | 1,336,003.0000 | 652,311,000 | 4.57% | 0.01% |
| Feb. 26, 2025 | EBSWORTH DAVID R | Director | M | Ordinary Shares | 100000 | $1.93 | 1,400,003.0000 | 652,311,000 | 7.69% | 0.02% |
| Feb. 26, 2025 | EBSWORTH DAVID R | Director | M | Ordinary Shares | 96000 | $2.67 | 1,300,003.0000 | 652,311,000 | 7.97% | 0.01% |
| Feb. 26, 2025 | EBSWORTH DAVID R | Director | M | Ordinary Shares | 64000 | $0.78 | 1,004,003.0000 | 652,311,000 | 6.81% | 0.01% |
| Feb. 3, 2025 | Rickard Kathleen A. | Chief Medical Officer | F | Ordinary Shares | 33240 | $7.16 | 2,688,240.0000 | 652,311,000 | 1.22% | 0.01% |
| Feb. 1, 2025 | ZACCARDELLI DAVID | President and CEO | A | Ordinary Shares | 200000 | $0.00 | 14,404,752.0000 | 652,311,000 | 1.41% | 0.03% |
| Feb. 3, 2025 | ZACCARDELLI DAVID | President and CEO | F | Ordinary Shares | 166728 | $7.16 | 14,238,024.0000 | 652,311,000 | 1.16% | 0.03% |
| Feb. 1, 2025 | Hahn Mark W | Chief Financial Officer | A | Ordinary Shares | 200000 | $0.00 | 13,493,736.0000 | 652,311,000 | 1.50% | 0.03% |
| Feb. 3, 2025 | Hahn Mark W | Chief Financial Officer | F | Ordinary Shares | 166888 | $7.16 | 13,326,848.0000 | 652,311,000 | 1.24% | 0.03% |
| Feb. 1, 2025 | Rickard Kathleen A. | Chief Medical Officer | A | Ordinary Shares | 50000 | $0.00 | 2,721,480.0000 | 652,311,000 | 1.87% | 0.01% |
| Dec. 5, 2024 | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 640048 | $5.01 | 13,477,464.0000 | 648,217,000 | 4.53% | 0.10% |
| Dec. 4, 2024 | ZACCARDELLI DAVID | President and CEO | S | Ordinary Shares | 67608 | $5.00 | 15,007,816.0000 | 648,217,000 | 0.45% | 0.01% |
| Dec. 5, 2024 | ZACCARDELLI DAVID | President and CEO | S | Ordinary Shares | 640264 | $5.01 | 14,367,552.0000 | 648,217,000 | 4.27% | 0.10% |
| Dec. 6, 2024 | ZACCARDELLI DAVID | President and CEO | S | Ordinary Shares | 162800 | $5.01 | 14,204,752.0000 | 648,217,000 | 1.13% | 0.03% |
| Dec. 4, 2024 | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 58184 | $5.00 | 14,117,512.0000 | 648,217,000 | 0.41% | 0.01% |
| Dec. 6, 2024 | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 183728 | $5.01 | 13,293,736.0000 | 648,217,000 | 1.36% | 0.03% |
| Nov. 27, 2024 | ZACCARDELLI DAVID | President and CEO | S | Ordinary Shares | 23240 | $5.00 | 15,177,512.0000 | 648,217,000 | 0.15% | 0.00% |
| Nov. 27, 2024 | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 12936 | $5.00 | 14,276,000.0000 | 648,217,000 | 0.09% | 0.00% |
| Nov. 29, 2024 | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 98704 | $5.01 | 14,177,296.0000 | 648,217,000 | 0.69% | 0.02% |
| Dec. 2, 2024 | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 1600 | $5.00 | 14,175,696.0000 | 648,217,000 | 0.01% | 0.00% |
| Nov. 29, 2024 | ZACCARDELLI DAVID | President and CEO | S | Ordinary Shares | 98888 | $5.01 | 15,078,624.0000 | 648,217,000 | 0.65% | 0.02% |
| Dec. 2, 2024 | ZACCARDELLI DAVID | President and CEO | S | Ordinary Shares | 3200 | $5.00 | 15,075,424.0000 | 648,217,000 | 0.02% | 0.00% |
| Nov. 25, 2024 | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 1600 | $5.00 | 14,289,736.0000 | 648,217,000 | 0.01% | 0.00% |
| Nov. 26, 2024 | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 800 | $5.00 | 14,288,936.0000 | 648,217,000 | 0.01% | 0.00% |
| Nov. 25, 2024 | ZACCARDELLI DAVID | President and CEO | S | Ordinary Shares | 1600 | $5.00 | 15,200,752.0000 | 648,217,000 | 0.01% | 0.00% |
| Nov. 25, 2024 | Rickard Kathleen A. | Chief Medical Officer | S | Ordinary Shares | 240000 | $4.90 | 2,671,480.0000 | 648,217,000 | 8.24% | 0.04% |
| Nov. 18, 2024 | EBSWORTH DAVID R | Director | P | Ordinary Shares | 20000 | $4.44 | 940,003.0000 | 648,217,000 | 2.17% | 0.00% |
| Nov. 11, 2024 | ZACCARDELLI DAVID | President and CEO | S | Ordinary Shares | 2400 | $5.00 | 15,202,352.0000 | 648,217,000 | 0.02% | 0.00% |
| Nov. 11, 2024 | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 2400 | $5.00 | 14,291,336.0000 | 648,217,000 | 0.02% | 0.00% |
| Nov. 6, 2024 | EBSWORTH DAVID R | Director | P | Ordinary Shares | 39360 | $4.80 | 920,003.0000 | 648,217,000 | 4.47% | 0.01% |
| Nov. 6, 2024 | ACKERMANN CHRISTINA | Director | P | Ordinary Shares | 41880 | $4.74 | 41,880.0000 | 648,217,000 | 9999.99% | 0.01% |
| Nov. 1, 2024 | ZACCARDELLI DAVID | President and CEO | S | Ordinary Shares | 46888 | $4.38 | 15,298,896.0000 | 648,217,000 | 0.31% | 0.01% |
| Nov. 4, 2024 | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 80784 | $4.39 | 14,293,736.0000 | 648,217,000 | 0.56% | 0.01% |
| Nov. 1, 2024 | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 48888 | $4.38 | 14,374,520.0000 | 648,217,000 | 0.34% | 0.01% |
| Nov. 4, 2024 | ZACCARDELLI DAVID | President and CEO | S | Ordinary Shares | 94144 | $4.39 | 15,204,752.0000 | 648,217,000 | 0.62% | 0.01% |
| Oct. 30, 2024 | Fisher Andrew | General Counsel | A | Ordinary Shares | 300000 | $0.00 | 300,000.0000 | 648,217,000 | 9999.99% | 0.05% |
| Nov. 1, 2024 | Hahn Mark W | Chief Financial Officer | F | Ordinary Shares | 245952 | $4.24 | 14,423,408.0000 | 648,217,000 | 1.68% | 0.04% |
| Nov. 1, 2024 | Hahn Mark W | Chief Financial Officer | A | Ordinary Shares | 200000 | $0.00 | 14,669,360.0000 | 648,217,000 | 1.38% | 0.03% |
| Nov. 1, 2024 | ZACCARDELLI DAVID | President and CEO | F | Ordinary Shares | 245952 | $4.24 | 15,345,784.0000 | 648,217,000 | 1.58% | 0.04% |
| Oct. 30, 2024 | Rickard Kathleen A. | Chief Medical Officer | A | Ordinary Shares | 300000 | $0.00 | 2,927,416.0000 | 648,217,000 | 11.42% | 0.05% |
| Nov. 1, 2024 | Rickard Kathleen A. | Chief Medical Officer | A | Ordinary Shares | 50000 | $0.00 | 2,977,416.0000 | 648,217,000 | 1.71% | 0.01% |
| Nov. 1, 2024 | Rickard Kathleen A. | Chief Medical Officer | F | Ordinary Shares | 65936 | $4.24 | 2,911,480.0000 | 648,217,000 | 2.21% | 0.01% |
| Oct. 30, 2024 | Hahn Mark W | Chief Financial Officer | A | Ordinary Shares | 800000 | $0.00 | 14,469,360.0000 | 648,217,000 | 5.85% | 0.12% |
| Oct. 30, 2024 | ZACCARDELLI DAVID | President and CEO | A | Ordinary Shares | 800000 | $0.00 | 15,391,736.0000 | 648,217,000 | 5.48% | 0.12% |
| Nov. 1, 2024 | ZACCARDELLI DAVID | President and CEO | A | Ordinary Shares | 200000 | $0.00 | 15,591,736.0000 | 648,217,000 | 1.30% | 0.03% |
| Oct. 24, 2024 | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 141360 | $4.38 | 13,672,560.0000 | 648,217,000 | 1.02% | 0.02% |
| Oct. 25, 2024 | ZACCARDELLI DAVID | President and CEO | S | Ordinary Shares | 4800 | $4.38 | 14,591,736.0000 | 648,217,000 | 0.03% | 0.00% |
| Oct. 24, 2024 | ZACCARDELLI DAVID | President and CEO | S | Ordinary Shares | 140000 | $4.38 | 14,596,536.0000 | 648,217,000 | 0.95% | 0.02% |
| Oct. 23, 2024 | ZACCARDELLI DAVID | President and CEO | S | Ordinary Shares | 16 | $4.38 | 14,736,536.0000 | 648,217,000 | 0.00% | 0.00% |
| Oct. 25, 2024 | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 3200 | $4.38 | 13,669,360.0000 | 648,217,000 | 0.02% | 0.00% |
| Oct. 18, 2024 | ZACCARDELLI DAVID | President and CEO | S | Ordinary Shares | 245784 | $4.38 | 15,004,920.0000 | 648,217,000 | 1.61% | 0.04% |
| Oct. 22, 2024 | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 159344 | $4.38 | 13,813,920.0000 | 648,217,000 | 1.14% | 0.02% |
| Oct. 21, 2024 | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 116696 | $4.38 | 13,973,264.0000 | 648,217,000 | 0.83% | 0.02% |
| Oct. 18, 2024 | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 249728 | $4.38 | 14,089,960.0000 | 648,217,000 | 1.74% | 0.04% |
| Oct. 22, 2024 | ZACCARDELLI DAVID | President and CEO | S | Ordinary Shares | 157912 | $4.39 | 14,736,552.0000 | 648,217,000 | 1.06% | 0.02% |
| Oct. 21, 2024 | ZACCARDELLI DAVID | President and CEO | S | Ordinary Shares | 110456 | $4.38 | 14,894,464.0000 | 648,217,000 | 0.74% | 0.02% |
| Sept. 11, 2024 | ZACCARDELLI DAVID | President and CEO | S | Ordinary Shares | 600000 | $3.76 | 15,250,704.0000 | 648,217,000 | 3.79% | 0.09% |
| Sept. 11, 2024 | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 600000 | $3.76 | 14,339,688.0000 | 648,217,000 | 4.02% | 0.09% |
| Aug. 12, 2024 | EBSWORTH DAVID R | Director | P | Ordinary Shares | 36000 | $2.87 | 880,643.0000 | 648,217,000 | 4.26% | 0.01% |
| Aug. 13, 2024 | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 3736 | $3.25 | 14,939,688.0000 | 648,217,000 | 0.03% | 0.00% |
| Aug. 13, 2024 | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 394664 | $3.20 | 14,943,424.0000 | 648,217,000 | 2.57% | 0.06% |
| Aug. 12, 2024 | Hahn Mark W | Chief Financial Officer | S | Ordinary Shares | 1600 | $3.13 | 15,338,088.0000 | 648,217,000 | 0.01% | 0.00% |
| Aug. 13, 2024 | ZACCARDELLI DAVID | President and CEO | S | Ordinary Shares | 390184 | $3.20 | 15,858,920.0000 | 648,217,000 | 2.40% | 0.06% |
| Aug. 13, 2024 | ZACCARDELLI DAVID | President and CEO | S | Ordinary Shares | 8216 | $3.25 | 15,850,704.0000 | 648,217,000 | 0.05% | 0.00% |
| Aug. 12, 2024 | ZACCARDELLI DAVID | President and CEO | S | Ordinary Shares | 1600 | $3.13 | 16,249,104.0000 | 648,217,000 | 0.01% | 0.00% |
| Aug. 7, 2024 | ZACCARDELLI DAVID | President and CEO | F | Ordinary Shares | 314800 | $2.62 | 16,250,704.0000 | 648,217,000 | 1.90% | 0.05% |
| Aug. 7, 2024 | Hahn Mark W | Chief Financial Officer | F | Ordinary Shares | 314800 | $2.62 | 15,339,688.0000 | 648,217,000 | 2.01% | 0.05% |
| Aug. 7, 2024 | Hahn Mark W | Chief Financial Officer | A | Ordinary Shares | 800000 | $0.00 | 15,654,488.0000 | 648,217,000 | 5.39% | 0.12% |
| Aug. 7, 2024 | Rickard Kathleen A. | Chief Medical Officer | F | Ordinary Shares | 87904 | $2.62 | 2,627,416.0000 | 648,217,000 | 3.24% | 0.01% |
| Aug. 7, 2024 | Rickard Kathleen A. | Chief Medical Officer | A | Ordinary Shares | 200000 | $0.00 | 2,715,320.0000 | 648,217,000 | 7.95% | 0.03% |
| Aug. 7, 2024 | ZACCARDELLI DAVID | President and CEO | A | Ordinary Shares | 800000 | $0.00 | 16,565,504.0000 | 648,217,000 | 5.07% | 0.12% |
| Aug. 1, 2024 | Rickard Kathleen A. | Chief Medical Officer | F | Ordinary Shares | 106232 | $2.83 | 2,515,320.0000 | 648,217,000 | 4.05% | 0.02% |
| Aug. 1, 2024 | ZACCARDELLI DAVID | President and CEO | F | Ordinary Shares | 88544 | $2.83 | 15,765,504.0000 | 648,217,000 | 0.56% | 0.01% |
| Aug. 1, 2024 | Hahn Mark W | Chief Financial Officer | F | Ordinary Shares | 88544 | $2.83 | 14,854,488.0000 | 648,217,000 | 0.59% | 0.01% |
| May 1, 2024 | ZACCARDELLI DAVID | President and CEO | F | Ordinary Shares | 88544 | $1.93 | 15,854,048.0000 | 634,143,000 | 0.56% | 0.01% |
| May 1, 2024 | Hahn Mark W | Chief Financial Officer | F | Ordinary Shares | 88544 | $1.93 | 14,943,032.0000 | 634,143,000 | 0.59% | 0.01% |
| May 1, 2024 | Rickard Kathleen A. | Chief Medical Officer | F | Ordinary Shares | 73824 | $1.93 | 2,657,800.0000 | 634,143,000 | 2.70% | 0.01% |
| May 3, 2024 | Rickard Kathleen A. | Chief Medical Officer | S | Ordinary Shares | 36248 | $1.96 | 2,621,552.0000 | 634,143,000 | 1.36% | 0.01% |
| April 29, 2024 | EBSWORTH DAVID R | Director | A | Share Options (Right to Buy) | 240000 | $0.00 | 240,000.0000 | 634,143,000 | 9999.99% | 0.04% |
| April 29, 2024 | Sinha Vikas | Director | A | Share Options (Right to Buy) | 240000 | $0.00 | 240,000.0000 | 634,143,000 | 9999.99% | 0.04% |
| April 29, 2024 | Edwards Martin | Director | A | Share Options (Right to Buy) | 240000 | $0.00 | 240,000.0000 | 634,143,000 | 9999.99% | 0.04% |
| April 29, 2024 | Cunningham Kenneth | Director | A | Share Options (Right to Buy) | 240000 | $0.00 | 240,000.0000 | 634,143,000 | 9999.99% | 0.04% |
| April 29, 2024 | Brady James Aloysius | Director | A | Share Options (Right to Buy) | 240000 | $0.00 | 240,000.0000 | 634,143,000 | 9999.99% | 0.04% |
| April 29, 2024 | Deschamps Lisa | Director | A | Share Options (Right to Buy) | 240000 | $0.00 | 240,000.0000 | 634,143,000 | 9999.99% | 0.04% |
| April 29, 2024 | SHAH MAHENDRA | Director | A | Share Options (Right to Buy) | 240000 | $0.00 | 240,000.0000 | 634,143,000 | 9999.99% | 0.04% |
| April 29, 2024 | ACKERMANN CHRISTINA | Director | A | Share Options (Right to Buy) | 240000 | $0.00 | 240,000.0000 | 634,143,000 | 9999.99% | 0.04% |
| April 29, 2024 | Ullman Anders | Director | A | Share Options (Right to Buy) | 240000 | $0.00 | 240,000.0000 | 634,143,000 | 9999.99% | 0.04% |
| April 1, 2024 | Fisher Andrew | General Counsel | A | Share Options (Right to Buy) | 2400000 | $0.00 | 2,400,000.0000 | 634,143,000 | 9999.99% | 0.38% |
| Feb. 1, 2024 | ZACCARDELLI DAVID | President and CEO | F | Ordinary Shares | 480200 | $2.29 | 15,942,592.0000 | 634,143,000 | 2.92% | 0.08% |
| Feb. 1, 2024 | Rickard Kathleen A. | Chief Medical Officer | F | Ordinary Shares | 72768 | $2.29 | 2,767,872.0000 | 634,143,000 | 2.56% | 0.01% |
| Feb. 1, 2024 | Poll Claire | General Counsel | G | Ordinary Shares | 116592 | $0.00 | 2,800,407.0000 | 634,143,000 | 4.34% | 0.02% |
| Feb. 1, 2024 | Hahn Mark W | Chief Financial Officer | F | Ordinary Shares | 480664 | $2.29 | 15,031,576.0000 | 634,143,000 | 3.10% | 0.08% |
| Feb. 5, 2024 | Rickard Kathleen A. | Chief Medical Officer | S | Ordinary Shares | 36248 | $2.22 | 2,731,624.0000 | 634,143,000 | 1.31% | 0.01% |
| Feb. 1, 2024 | Poll Claire | General Counsel | F | Ordinary Shares | 103408 | $2.29 | 2,916,999.0000 | 634,143,000 | 3.42% | 0.02% |
| Feb. 1, 2024 | Poll Claire | General Counsel | G | Ordinary Shares | 116592 | $0.00 | 2,800,407.0000 | 634,143,000 | 4.00% | 0.02% |
| Feb. 1, 2024 | Austwick Michael | Director | A | Share Options (Right to Buy) | 144000 | $0.00 | 144,000.0000 | 634,143,000 | 9999.99% | 0.02% |